Greg A Lazar

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Single Molecule

Genetic Diversity

Top Venues

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew G Romei, Brandon Leonard, Zachary B Katz, Daniel Le, Yanli Yang, Eric S Day, Christopher W Koo, Preeti Sharma, Jack Bevers, Ingrid Kim, Huiguang Dai, Farzam Farahi, May Lin, Andrey S Shaw, Gerald Nakamura, Jonathan T Sockolosky, Greg A Lazar
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists. Nature communications 15 (1) (2024)
Matthew G Romei, Brandon Leonard, Zachary B Katz, Daniel Le, Yanli Yang, Eric S Day, Christopher W Koo, Preeti Sharma, Jack Bevers, Ingrid Kim, Huiguang Dai, Farzam Farahi, May Lin, Andrey S Shaw, Gerald Nakamura, Jonathan T Sockolosky, Greg A Lazar
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists. Nature communications 15 (1) (2024)
Matthew G Romei, Brandon Leonard, Zachary B Katz, Daniel Le, Yanli Yang, Eric S Day, Christopher W Koo, Preeti Sharma, Jack Bevers, Ingrid Kim, Huiguang Dai, Farzam Farahi, May Lin, Andrey S Shaw, Gerald Nakamura, Jonathan T Sockolosky, Greg A Lazar
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists. Nature communications 15 (1) (2024)
Matthew G Romei, Brandon Leonard, Zachary B Katz, Daniel Le, Yanli Yang, Eric S Day, Christopher W Koo, Preeti Sharma, Jack Bevers, Ingrid Kim, Huiguang Dai, Farzam Farahi, May Lin, Andrey S Shaw, Gerald Nakamura, Jonathan T Sockolosky, Greg A Lazar
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists. Nature communications 15 (1) (2024)
Rickvinder Besla, Elicia Penuel, Geoffrey Del Rosario, Ely Cosino, Szymon Myrta, Michael Dillon, Greg A Lazar, Dorothee Nickles, Christoph Spiess, Shang-Fan Yu, Andrew G Polson
T cell-Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing. Cancer immunology research (2023)